BioCardia, Inc.

BCDANasdaqCIK 925741HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 369 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

BioCardia, Inc., Reports and events
Filed	Form	What it is	Accession number
2021-05-1307:30 ET	10-Q	Quarterly reportPeriod 2021-03-31	0001437749-21-011911
2021-04-3016:37 ET	DEF 14A	Proxy statementPeriod 2021-06-15	0001437749-21-010470
2021-04-2717:21 ET	8-K	5.02 Departure or appointment of officers or directors	0001437749-21-009931
2021-04-2608:05 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-21-009749
2021-03-3119:16 ET	8-K	8.01 Other events	0001437749-21-007712
2021-03-3008:30 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-21-007563
2021-03-3007:30 ET	10-K	Annual reportPeriod 2020-12-31	0001437749-21-007543
2021-03-2916:19 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001437749-21-007456
2021-02-2308:00 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-21-003702
2021-02-1708:30 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-21-003055
2021-02-0208:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001437749-21-001718
2021-01-1108:31 ET	8-K	5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-21-000466
2020-12-2816:54 ET	8-K	5.07 Shareholder vote results	0001437749-20-025972
2020-12-2117:28 ET	8-K/A	9.01 Financial statements and exhibits	0001437749-20-025733
2020-12-1708:30 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-20-025512
2020-12-1606:02 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-20-025430
2020-12-1516:08 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-20-025392
2020-12-1414:28 ET	8-K	8.01 Other events	0001437749-20-025263
2020-12-0217:57 ET	DEF 14A	Proxy statementPeriod 2020-12-22	0001437749-20-024669
2020-12-0108:00 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-20-024608
2020-11-1317:53 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0001437749-20-023683
2020-11-1007:30 ET	10-Q	Quarterly reportPeriod 2020-09-30	0001437749-20-023294
2020-10-2707:30 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-20-021674
2020-10-0907:30 ET	8-K	8.01 Other events	0001437749-20-020951
2020-08-1306:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001437749-20-017720
2020-08-1306:06 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001437749-20-017718
2020-07-0707:28 ET	8-K	8.01 Other events	0001437749-20-014698
2020-06-1917:09 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-20-013492
2020-06-1508:28 ET	S-1/A	Registration statement, amended	0001437749-20-013084
2020-05-2621:50 ET	S-1/A	Registration statement, amended	0001437749-20-011690
2020-05-1507:26 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001437749-20-010860
2020-05-0806:02 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits	0001437749-20-009907
2020-05-0621:22 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001437749-20-009495
2020-04-2816:15 ET	8-K	5.02 Departure or appointment of officers or directors	0001437749-20-008697
2020-04-2116:17 ET	8-K	3.01 Delisting notice	0001437749-20-008127
2020-04-1407:30 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001437749-20-007637
2020-04-0913:54 ET	10-K	Annual reportPeriod 2019-12-31	0001437749-20-007405
2020-02-1319:21 ET	S-1	Registration statement	0001437749-20-002488
2019-11-2907:29 ET	8-K	5.07 Shareholder vote results	0001437749-19-023681
2019-11-1916:52 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-19-295625
2019-11-1916:02 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001437749-19-023200
2019-11-0607:11 ET	8-K	8.01 Other events	0001437749-19-021643
2019-10-2316:28 ET	SC 13D/A	Ownership report, active investor, amended	0000944809-19-000073
2019-10-1516:04 ET	DEF 14A	Proxy statementPeriod 2019-11-26	0001437749-19-020061
2019-10-0208:01 ET	SC 13D	Ownership report, active investor	0001437749-19-019406
2019-09-2716:25 ET	8-K	5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events	0001437749-19-019165
2019-09-1716:42 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001437749-19-018537
2019-08-3016:02 ET	8-K	1.02 Termination of a material agreement	0001437749-19-017694
2019-08-1416:01 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001437749-19-016798
2019-08-0720:21 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits	0001437749-19-015673

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 21:12 ET. Listed shows no prices and gives no investment advice.